Cationic lipid polymerization as a novel approach for constructing new DNA delivery agents

Area of Science:

• Biotechnology
• Gene Therapy
• Materials Science

Background:

• In vivo gene delivery using cationic lipids is hindered by protein-induced aggregation in blood.
• Existing lipid-DNA complexes often lack stability, impacting their therapeutic efficacy.
• There is a need for more stable and less toxic delivery systems for gene therapy.

Purpose of the Study:

• To develop a novel poly(cationic lipid) (PCL) for enhanced stability of cationic polyplexes in gene transfection.
• To evaluate the stability, toxicity, and transfection activity of PCL compared to monomeric lipids and commercial standards.
• To investigate the impact of lipid polymerization on gene delivery performance.

Main Methods:

• Synthesized a poly(cationic lipid) (PCL) from a polymerizable precursor (betaAE-DMRI) and its monomeric derivative (MHL).
• Formulated various cationic liposomes including MHL, MHL-cholesterol (Chol), PCL, PCL-Chol, DOTAP-Chol, and Lipofectamine.
• Assessed toxicity using LDH leakage assay on rat hepatocytes and Hep G2 cells.
• Evaluated serum stability by exposing liposome suspensions to fetal bovine serum (FBS).
• Determined transfection activity using a luciferase vector (pGL3) in Hep G2 and Alexander cell lines.

Main Results:

• PCL formulations exhibited significantly lower toxicity compared to MHL, DOTAP-Chol, and Lipofectamine.
• PCL suspensions demonstrated remarkable resistance to aggregation in 50% and 100% FBS for 24 hours.
• Lipid polymerization did not compromise transfection activity, with PCL formulations showing comparable luciferase expression to controls.

Conclusions:

• The novel poly(cationic lipid) (PCL) offers superior stability and reduced cytotoxicity for gene delivery applications.
• PCL demonstrates significant resistance to serum-induced aggregation, a key challenge in in vivo gene delivery.
• This polymerization approach provides a valuable alternative for developing stable and effective polyplexes for in vivo gene delivery.